DEPO-MEDROL WITH LIDOCAINE
Google image searchProduct monograph
Active ingredients
methylprednisolone acetate, 40 MG/ML
lidocaine hydrochloride, 10 MG/ML
DIN: 00260428
Dosage form(s): SUSPENSION
Route(s) of administration: INTRA-ARTICULAR, PERIARTICULAR, INTRABURSAL, INTRASYNOVIAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 20-MAY-2022
ATC:
- H02 — CORTICOSTEROIDS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- H02B — CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS (ATC, ATC/DDD)
- H02BX — Corticosteroids for systemic use, combinations (ATC, ATC/DDD)
- H02BX01 — METHYLPREDNISOLONE, COMBINATIONS (ATC/DDD)
Reference brand drug: Depo-medrol With Lidocaine
Pharmaceutical standard: USP
